Parkinson's disease. Extrapyramidal and movement disorders
Conditions
Interventions
Intervention 1: Intervention group: receives 12 sessions of sensory reweighting as a method of balance exercises (3 sessions per week, 45-60 minutes per session). Exercises include proprioceptive, vis
Rehabilitation
Intervention group: receives 12 sessions of sensory reweighting as a method of balance exercises (3 sessions per week, 45-60 minutes per session). Exercises include proprioceptive, visual, vestibular,
Control group: does not receive these exercises.
Sponsors
Vice Chancellor for research of Iran University of Medical Sciences, Dr. Seyed Ali Javad Moosavi
Eligibility
Sex/Gender
All
Age
55 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Having Parkinson's disease according to neurologist diagnosis; Having the disease progression level of 1 to 3 according to Hoehn and Yahr Scale; Having an acceptable level of cognitive function, i.e. score of more than 21 on the Mini Mental Status Examination (MMSE); Having the ability to walk independently and without assistive device at least 10 meters in length; Having at least a fifth grade education; Having the ability to perform the most difficult condition of laboratory test (quiet standing for 180 seconds while vibration is applied on the Achilles tendons of both sides and attention to visual stimulus); Having no other neurological diseases such as stroke according to the patient, or the patient's family or physician report; Not having any orthopedic problem (such as low back pain, arthritis, Hallux valgus, flat foot) according to the patient, or the patient's family or physician report; Not having diabetes or addiction according to the patient, or the patient's family or physician report; No history of falling during the past month according to the patient, or the patient's family report. Exclusion Criteria: Lack of patient cooperation during the test or exercises; Not return for doing tests after the intervention; Entering to the nonpharmacologic on-off phase of the disease during the study according to neurologist diagnosis; Change in the pharmacologic regimen of the patient during the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postural control. Timepoint: before and after intervention. Method of measurement: forceplate. | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional balance and mobility. Timepoint: before and after intervention. Method of measurement: Fuctional reach test, Berg Balance Scale, Time Up&Go test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhorban Taghizadeh
Iran University of Medical Sciences
Outcome results
None listed